Quantifying the hospital and emergency department costs for women diagnosed with breast cancer in Queensland
- 22 October 2021
- journal article
- research article
- Published by Springer Nature in Supportive Care in Cancer
- Vol. 30 (3) , 2141-2150
Abstract
Purpose With increasing rates of cancer survival due to advances in screening and treatment options, the costs of breast cancer diagnoses are attracting interest. However, limited research has explored the costs to the Australian healthcare system associated with breast cancer. We aimed to describe the cost to hospital funders for hospital episodes and emergency department (ED) presentations for Queensland women with breast cancer, and whether costs varied by demographic characteristics. Methods We used a linked administrative dataset, CancerCostMod, limited to all breast cancer diagnoses aged 18 years or over in Queensland between July 2011 and June 2015 (n = 13,285). Each record was linked to Queensland Health Admitted Patient Data Collection and Emergency Department Information Systems records between July 2011 and June 2018. The cost of hospital episodes and ED presentations were determined, with mean costs per patient modelled using generalised linear models with a gamma distribution and log link function. Results The total cost to the Queensland healthcare system from hospital episodes for female breast cancer was AUD$309 million and AUD$12.6 million for ED presentations during the first 3 years following diagnosis. High levels of costs and service use were identified in the first 6 months following diagnosis. Some significant differences in cost of hospital and ED episodes were identified based on demographic characteristics, with Indigenous women and those from lower socioeconomic backgrounds having higher costs. Conclusion Hospitalisation costs for breast cancer in Queensland exert a high burden on the healthcare system. Costs are higher for women during the first 6 months from diagnosis and for Indigenous women, as well as those with underlying comorbidities and lower socioeconomic position.Keywords
This publication has 22 references indexed in Scilit:
- Breast cancer diagnosis, patterns of care and burden of disease in Queensland, Australia (1998–2004): does being Indigenous make a difference?International Journal of Public Health, 2015
- Presentation patterns and outcomes of patients with cancer accessing care in emergency departments in Victoria, AustraliaSupportive Care in Cancer, 2015
- Cost of cancer care for patients undergoing chemotherapy: The Elements of Cancer Care studyAsia-Pacific Journal of Clinical Oncology, 2015
- The Association between Charlson Comorbidity Index and the Medical Care Cost of Cancer: A Retrospective StudyBioMed Research International, 2015
- Increasing rates of surgical treatment and preventing comorbidities may increase breast cancer survival for Aboriginal womenBMC Cancer, 2014
- Impact of geographic location on surgical outcomes of women with breast cancerAnz Journal of Surgery, 2014
- Unplanned presentations to emergency departments due to chemotherapy induced complications: Opportunities for improving service deliveryAustralasian Emergency Nursing Journal, 2011
- Geographic remoteness, area-level socio-economic disadvantage and advanced breast cancer: a cross-sectional, multilevel studyJournal of Epidemiology and Community Health, 2011
- Trends in Area-Socioeconomic and Race-Ethnic Disparities in Breast Cancer Incidence, Stage at Diagnosis, Screening, Mortality, and Survival among Women Ages 50 Years and Over (1987-2005)Cancer Epidemiology, Biomarkers & Prevention, 2009
- New ICD-10 version of the Charlson comorbidity index predicted in-hospital mortalityJournal of Clinical Epidemiology, 2004